Wird geladen...
NMO-IgG Status in Fulminant Inflammatory CNS Demyelinating Disorders
BACKGROUND: The aquaporin-4-specific serum autoantibody, NMO-IgG, is a validated biomarker distinguishing neuromyelitis optica spectrum disorders (NMOSD) from multiple sclerosis (MS). Because fulminant attacks are more common in NMOSD than MS, some suggest that NMO-IgG may be a marker of destructive...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2009
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2742779/ https://ncbi.nlm.nih.gov/pubmed/19667216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.2009.152 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|